SCHEMBL3555229

SCHEMBL3555229

O=C(O)c1ccccc1OCCOc1ccc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.63
CACNA1B Q00975 3/20 0.55
CACNA1H O95180 2/20 0.55
ALDH1A1 P00352 1/20 0.53
CCR1 P32246 2/20 0.52
CCR2 P41597 2/20 0.52
GPR27 Q9NS67 5/20 0.50
AVPR2 P30518 4/20 0.50
ACLY P53396 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPT P10636 1/20 0.48
PKM P14618 2/20 0.48
MCL1 Q07820 1/20 0.47
RECQL P46063 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3562492 0.91 PSEN1 (0.57) ARCACNA1BCACNA1HALDH1A1CCR1
SCHEMBL3552950 0.90 PTPN5 (0.54) ARCACNA1BALDH1A1MEN1KMT2A
SCHEMBL3557987 0.90 ALDH1A1 (0.53) ARCACNA1BALDH1A1GPR27AVPR2
SCHEMBL3559135 0.89 AR (0.62) ARCACNA1BCACNA1HALDH1A1CCR2
SCHEMBL3558986 0.89 ALDH1A1 (0.63) ARCACNA1BALDH1A1MEN1KMT2A
SCHEMBL3564010 0.87 ALDH1A1 (0.58) ARCACNA1BALDH1A1MEN1KMT2A
SCHEMBL3563348 0.87 ALDH1A1 (0.58) ARCACNA1BALDH1A1MEN1KMT2A
SCHEMBL3560145 0.87 MEN1 (0.51) ARCACNA1BALDH1A1MEN1KMT2A
SCHEMBL3559276 0.86 AR (0.61) ARCACNA1BALDH1A1MEN1KMT2A
SCHEMBL3561723 0.86 PGR (0.57) CACNA1BALDH1A1GPR27AVPR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 AR 3412/4885CACNA1B 1921/4885CACNA1H 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.